This intimation is to inform Doctors, Patients, Stockists and Chemists about a shortage of our Brand Cilimin Capsules, (D - Penicillamine IP 250 mg) used for treatment of Wilson's Disease, Rheumatoid Arthritis and other conditions. This happened due to a sudden disruption of supply of raw material of D-Penicillamin by our approved supplier beyond the control of the Company. Since then the company has been working very hard with alternative suppliers for the early resumption of supplies.
With continuous efforts of the Company we are pleased to inform that as of today we expect availability of Cilamin Capsules by end September, 2016.
We regret the inconvenience caused to all in this respect.
Head Supply Chain Management
Panacea Biotec Ltd.
Mobile No: 9816620111
This website is not intended to provide advice on personal medical matters or to substitute for consultation with a physician. The WDA does not accept advertising for this website.
1732 First Avenue #20043. New York, NY. 10128 | 866-961-0533 or 414-961-0533